Connect with us

Technology

New Survey Shows Strong Patient Support for Personalized Obesity Interventions

Published

2 months ago

on

Respondents ages 18 to 65 highlight urgency for medical recognition, scientifically proven interventions, and genetic testing for personalized obesity treatment.

MENLO PARK, Calif., Aug. 1, 2024 /PRNewswire/ — Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, today announces the results from a new U.S. weight loss survey from 475 patients who have struggled with excess weight or are currently overweight or obese. The survey provides valuable insights into patients’ evolving preferences for obesity treatment, how they receive this information, and what that means for the future of anti-obesity medications, like GLP-1s.

The survey findings reveal the majority of patients are interested in treating obesity as a medical condition. Two-thirds (66 percent) of patients surveyed prefer guidance from clinical care providers to manage their weight loss. The survey also highlights patients’ growing desire to personalize obesity care to their specific needs. Nearly two-thirds of patients surveyed (62 percent) are interested in learning more about their condition through genetic testing and want an obesity intervention tailored to their genetic findings. This data indicates strong momentum for personalized medicine as a cornerstone in the treatment of obesity. In addition, 53 percent of them are willing to pay for a genetic obesity test.

“Getting expert clinical advice on managing weight loss, as opposed to information readily consumed on social media platforms, is vital for patients’ ongoing success in their weight loss journey,” said Zaid Jabbar, M.D., M.S., obesity medicine physician with Duly Health and Care. “This survey shows that patients are more likely than ever to talk with their provider about taking control of their weight loss, and we know that involving a healthcare provider improves treatment adherence significantly. By offering the MyPhenome test in our clinic, we believe we can now offer better care and positively impact patients’ perspectives on their weight loss journey, ultimately changing the conversation with our patients for the better.”

While the patient perspective is shifting to a more clinical mindset surrounding obesity care, respondents largely noted they first learned about GLP-1s and weight loss medications via TV (36 percent) and social media, including TikTok (28 percent), Instagram/Facebook (26 percent) and Twitter/X (20 percent). This is in contrast to just 17 percent hearing about it from a healthcare provider, showcasing a continued need for patient education and communication surrounding clinical weight loss solutions backed by scientific evidence.

“The results of this survey reflect a notable evolution for obesity treatment. The new obesity medications have reinforced the long overdue need to treat obesity as a disease and it’s clear patients welcome that change. However, as this transition continues, it is clear, too, that there needs to be more focus on how patients receive weight loss information and utilize available treatments backed by scientific research,” says Mark Bagnall, CEO of Phenomix Sciences.

“We’ve seen that there is no ‘one-size-fits all’ solution, even with new and effective medications, and the average patient with obesity is now expressing a growing curiosity about the root causes of obesity. Our goal is to reach patients where they are, whether that’s providing the MyPhenomeTM test to obesity medicine providers in local markets and clinics or through telehealth platforms like Hello Alpha. These partnerships not only enhance patient outcomes but also contribute substantially to addressing and mitigating the global epidemic of obesity,” Bagnall said.

For more information about Phenomix Sciences, visit phenomixsciences.com.

About Phenomix Sciences
Phenomix Sciences is a precision obesity biotechnology company on a mission to conquer obesity globally through the use of our proprietary genetic tests, unique data sets and advanced analytics. Phenomix believes that the key to understanding obesity is its unprecedented access to clinical and molecular information throughout all stages and phenotypes of the disease. Phenomix leverages data intelligence to yield better accuracy in predicting individual patient response to specific weight loss interventions and reducing the variability in weight loss results for patients. For more information, please visit www.phenomixsciences.com.

Media Contact:
phenomix@ampublicrelations.com

View original content:https://www.prnewswire.com/news-releases/new-survey-shows-strong-patient-support-for-personalized-obesity-interventions-302212282.html

SOURCE Phenomix Sciences

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Eoptolink Releases OSFP 1.6T DR8 and 2FR4 Series Transceivers for AI/ML Clusters and Cloud Datacenter Networks

Published

26 mins ago

on

September 20, 2024

By

CHENGDU, China, Sept. 20, 2024 /PRNewswire/ — Eoptolink Technology Inc., Ltd. (SZSE: 300502), a leading innovator and provider of advanced optical transceiver solutions, announces the release of its OSFP 1.6T DR8/DR8-2 and 2xFR4 transceivers enabling the next generation high bandwidth networks for AI/ML clusters and cloud datacenters.

Eoptolink 1.6T OSFP transceivers have 8 electrical host interfacing lanes and 8 optical lanes operating at 212.5Gb/s (106GB with PAM4). Equipped with the industry’s latest DSP, these modules support transmission distances of up to 2km without the need to regenerate the FEC. The 1.6T DR8 and DR8-2 modules comes with either one MPO-16 adapter for point-to-point (P2P) connections or two MPO-12 adapters for 2x800G breakout applications. The 1.6T 2xFR4 modules are designed with a dual duplex LC connector running with 2 pairs of fibers only, which could help users to save fiber resources compared to DR8 and DR8-2 versions.

The 1.6T DR8/DR8-2 and 2FR4 Portfolio consists of: – 

EOLO-13T-5H-XMX    OSFP 1.6T DR8, 1×1.6TbE, 500m, MPO-16
EOLO-13T-5H-XDX    OSFP 1.6T DR8, 2x800GbE, 500m, Dual MPO-12
EOLO-13T-02-XMX    OSFP 1.6T DR8-2, 1×1.6TbE, 2km, MPO-16
EOLO-13T-02-XDX     OSFP 1.6T DR8-2, 2x800GbE, 2km, Dual MPO-12
EOLO-16T-02-XXX     OSFP 1.6T 2FR4, 2x800GbE, 2km, Dual Duplex LC

Eoptolink OSFP 1.6T transceivers feature both EML and SiPh-based solutions, and testing has demonstrated excellent performance. “We are very proud of our optical and RF design teams, says Sean Davies, VP Sales, Eoptolink Technology Inc., Ltd. “Our 1.6T OSFP modules do not need an additional FEC on the optical side and this results in lower latency and power consumption of the modules simplifying the complete system and helping our AI and cloud customers in their work.”

About Eoptolink

Eoptolink Technology Inc., Ltd. (SZSE: 300502), a publicly traded company in China, is a leading innovator and provider of advanced optical transceiver solution for data center, enterprise and telecom networks. Eoptolink is dedicated to research, develop, manufacture and markets a diverse portfolio of high-performance optical transceivers for AI, Cloud Data Center, 4G/5G wireless, Transport & Datacom and FTTX applications all over the world.

Contact Us

China(HQ):   

No.510 Wulian Avenue, Chengdu 610200

USA:   

3191 Laurelview Court, Fremont, CA 94538

Thailand:   

390/21 Moo 2, Khao Khan Song, Sriracha, Chonburi 20110

E-mail:  

sales@eoptolink.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/eoptolink-releases-osfp-1-6t-dr8-and-2fr4-series-transceivers-for-aiml-clusters-and-cloud-datacenter-networks-302253858.html

SOURCE Eoptolink Technology Inc., Ltd.

Continue Reading

Technology

Flat Ads Makes Its Mark at DMEXCO 2024: Showcasing Strength in Programmatic Advertising

Published

26 mins ago

on

September 20, 2024

By

COLOGNE, Germany, Sept. 20, 2024 /PRNewswire/ — In September, Flat Ads makes its mark at DMEXCO 2024, the prestigious European event of digital marketing and technology. The highly successful exhibition boasts 650 exhibitors, 850 speakers, and thousands of participants. At the event, Flat Ads showcased the strength of programmatic advertising platform in ad delivery, traffic optimization, and brand safety.

Flat Ads programmatic advertising platform has an exclusive developer traffic of 700 million and an extensive network spanning over 200 countries and regions worldwide. It cooperates with over 200 leading DSP/SSP partners, including FreeWheel, PubMatic and Criteo, leveraging an efficient and complete bidding system, as well as automatic delivery algorithms, to achieve precise marketing and advertising effectiveness maximization.

With its exclusive platform strategy algorithm, Flat Ads programmatic advertising platform can continuously conduct automatic exploration and matching based on the characteristics of DSP and traffic, optimize and adjust the algorithm model in real-time. This not only ensures the sustainability of DSP budgets, but also maximizes traffic utilization and enhances monetization revenue of advertisements.

Moreover, brand protection is among the top priorities of Flat Ads. In addition to accessing to authority agency Pixalate to test the effectiveness of ads, it has also accessed HUMAN, the global cybersecurity authority to safeguard its clients by preventing bot attacks, digital fraud and abuse, ensuring a stable, reliable, and secure programmatic advertising transaction platform.

By participating in DMEXCO 2024, Flat Ads showcased its outstanding strength and fruitful achievements in the programmatic advertising field, attracting the attention of numerous advertisers and developers for cooperation. Flat Ads boasts not only robust technical capabilities and innovative prowess, but also an active and open attitude towards emerging technologies, embracing and exploring them. It remains committed to providing more professional and efficient global marketing services to advertisers and developers worldwide, helping clients stand out in the fiercely competitive market and achieve business growth.

As a globally leading mobile advertising marketing platform, Flat Ads currently operates offices in Singapore, Indonesia, Hong Kong, and Guangzhou, serving over 1000 clients with global marketing solutions. If you’re interested in Flat Ads’ programmatic advertising services, please visit www.flat-ads.com.

View original content:https://www.prnewswire.co.uk/news-releases/flat-ads-makes-its-mark-at-dmexco-2024-showcasing-strength-in-programmatic-advertising-302253872.html

Continue Reading

Technology

Tulufan, Xinjiang: For the first time, a new energy plant and station has achieved “all-green electricity” operation

Published

1 hour ago

on

September 20, 2024

By

TULUFAN, China, Sept. 20, 2024 /PRNewswire/ — On September 19, employees of State Grid Tulufan Electric Power Supply Company came to State Power Investment Zhongli Tenghui Qiquanhu Photovoltaic Power Station to provide comprehensive technical support and guidance for new energy enterprises.

Seven wind power and photovoltaic power generation enterprises, including Xinjiang Jize Power Generation Company in Tulufan, have obtained 6.035 million KWH of grid electricity by purchasing 6,035 “green certificates” to achieve “green electricity – green electricity” and achieve green energy use in the whole link of new energy power generation.

The green power certificate, referred to as “green certificate”, is the only certificate that identifies the production and consumption of renewable energy power. Promoting the all-green operation of new energy power generation is an important measure to promote the green consumption of renewable energy.

“Before, we were just ‘producers’ of green electricity. Now the buyers of green certificates have become green electricity consumers, and the production process is fully green.” Qiquan Lake photovoltaic power station inspection officer Forzati Dilishati said.

Since the launch of the green electricity and green certificate market, State Grid Tulufan Electric Power Supply Company has actively promoted green electricity trading, promoted the supply of green electricity and green certificates in multiple scenarios, promoted the rapid promotion and popularization of related services in Tulufan, and helped build a new power system.

In the first eight months of this year, the cumulative volume of green electricity transactions in Xinjiang reached 1.174 billion KWH, 93.83 times that of the whole year of 2022.

 

View original content:https://www.prnewswire.com/apac/news-releases/tulufan-xinjiang-for-the-first-time-a-new-energy-plant-and-station-has-achieved-all-green-electricity-operation-302253902.html

SOURCE State Grid Tulufan Electric Power Supply Company

Continue Reading

Trending